This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Astra. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Curt-Eric Hagberg: Innovator in Pharmaceutical Formulations
Introduction
Curt-Eric Hagberg is a notable inventor based in Upplands Vasby, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations. His work has the potential to impact the medical community positively.
Latest Patents
Hagberg holds a patent for "Pharmaceutical formulations," which includes new pharmaceutical formulations comprising 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole or its optical isomers, as well as pharmaceutically acceptable salts or solvates thereof. This patent showcases his commitment to advancing pharmaceutical science.
Career Highlights
Curt-Eric Hagberg is associated with Aktiebolaget Astra, a prominent company in the pharmaceutical industry. His role there has allowed him to focus on developing innovative solutions that address various health challenges.
Collaborations
Hagberg has worked alongside esteemed colleagues such as Alan John Cross and Bernard R Boar. Their collaborative efforts have contributed to the advancement of pharmaceutical research and development.
Conclusion
Curt-Eric Hagberg's contributions to pharmaceutical formulations highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile